Acelyrin, Inc.
SLRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $423 | $115 | $0 | $0 |
| Gross Profit | -$423 | -$115 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $238,055 | $229,186 | $230,627 | $38,230 |
| G&A Expenses | $66,809 | $66,178 | $24,054 | $3,564 |
| SG&A Expenses | $66,809 | $63,663 | $24,054 | $3,564 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$423 | $0 | $0 | $0 |
| Operating Expenses | $304,441 | $292,849 | $254,681 | $41,794 |
| Operating Income | -$316,258 | -$422,064 | -$69,179 | -$41,794 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $68,032 | $40,423 | $4,407 | -$45 |
| Pre-Tax Income | -$248,226 | -$381,641 | -$64,772 | -$41,839 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$248,226 | -$381,641 | -$250,461 | -$41,839 |
| % Margin | – | – | – | – |
| EPS | -2.5 | -5.43 | -0.7 | -2.05 |
| % Growth | 54% | -675.7% | 65.9% | – |
| EPS Diluted | -2.5 | -5.43 | -0.7 | -2.05 |
| Weighted Avg Shares Out | 99,300 | 70,250 | 20,443 | 20,443 |
| Weighted Avg Shares Out Dil | 99,300 | 70,250 | 20,443 | 20,443 |
| Supplemental Information | – | – | – | – |
| Interest Income | $31,209 | $30,555 | $4,170 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $423 | $115 | $69 | $42 |
| EBITDA | -$247,803 | -$381,526 | -$64,703 | -$41,797 |
| % Margin | – | – | – | – |